Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Pulmonary Hypertension

Free Subscription 26.01.2026 1 Adv Respir Med 1 Am J Emerg Med 1 Am J Transl Res 1 Arterioscler Thromb Vasc Biol 1 Cell Mol Life Sci 1 Clin Exp Rheumatol 1 Clin Res Hepatol Gastroenterol 2 Cureus 1 Echocardiography 1 Eur Heart J Digit Health 1 Eur J Clin Invest 2 Eur Respir J 1 Hepatol Res 4 Hypertension 1 Int J Cardiol 1 Intern Emerg Med 2 J Heart Lung Transplant 1 J Hepatol 1 J Natl Med Assoc 1 JACC Case Rep 1 Mayo Clin Proc 1 Medicine (Baltimore) 1 medRxiv 1 Nat Med 1 Ocul Immunol Inflamm 2 Pulm Circ 1 Respir Res 1 Signal Transduct Target Ther 1 Stem Cell Res 1 Ther Adv Musculoskelet Dis 1 Ther Umsch 1 Vascul Pharmacol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Respir Med

1. DAGHER C, Thomas A, Al Absi S, Carollo B, et al
   Rapid Inpatient Uptitration of Inhaled Treprostinil in PH-ILD Patients with Severe Phenotype.
   Adv Respir Med. 2026;94:7.
   PubMed         Abstract available
   
   

   
   Am J Emerg Med

2. ADRIAN RJ, Eke OF, Al Jalbout N, Al Hariri M, et al
   Pulmonary hypertension in cardiac tamponade: An observational cohort study of in-hospital mortality and echocardiographic findings.
   Am J Emerg Med. 2026;102:55-61.
   PubMed         Abstract available
   
   

   
   Am J Transl Res

3. ZHANG Z, Zhang X, Duan F, Song Z, et al
   Efficacy and prognosis of multimodal angiography-interventions for chronic pulmonary artery stenosis and pulmonary hypertension.
   Am J Transl Res. 2025;17:9956-9967.
   PubMed         Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

4. YAMADA Y, Satoh T, Yaoita N, Yamada K, et al
   Pathogenesis of Pulmonary Artery Remodeling: TGF-Beta Signaling and Inhibin Subunit Beta A in Group 1 and 2 Pulmonary Hypertension.
   Arterioscler Thromb Vasc Biol. 2026 Jan 22. doi: 10.1161/ATVBAHA.125.322506.
   PubMed         Abstract available
   
   

   
   Cell Mol Life Sci

5. MA C, Wang Z, Zhu X, Pang X, et al
   Super enhancer-driven LINC01013 mediates hypoxia-induced mitochondrial dysfunction by HSPA9 to determine pulmonary arterial smooth muscle cell fate.
   Cell Mol Life Sci. 2026;83:57.
   PubMed         Abstract available
   
   

   
   Clin Exp Rheumatol

6. RIZZO C, La Barbera L, Guggino G
   Reply to the comment on: Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient.
   Clin Exp Rheumatol. 2026 Jan 20. doi: 10.55563.
   PubMed        
   
   

   
   Clin Res Hepatol Gastroenterol

7. ALSALEH T, Harb A, Chapagain P, Dakkak B, et al
   Prevalence and risk factors of portopulmonary hypertension in chronic liver disease: systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2026;50:102748.
   PubMed         Abstract available
   
   

   
   Cureus

8. DOTEGUCHI S, Matsugi E, Takashima S, Kawai R, et al
   Influence of Patient Characteristics on the Effectiveness of Inhaled Nitric Oxide Therapy for Pulmonary Hypertension Following Cardiac Surgery: A Post-marketing Surveillance in Japan.
   Cureus. 2025;17:e99788.
   PubMed         Abstract available
   
   
9. SHYLLESH H A, Memon TA, Guruswamy P, Shekha TAM, et al
   Pulmonary Alveolar Microlithiasis Coexisting With Rheumatic Heart Disease and Severe Pulmonary Hypertension: A Case Report.
   Cureus. 2025;17:e99674.
   PubMed         Abstract available
   
   

   
   Echocardiography

10. WREN JT JR, Joshi R, McNamara PJ
    Navigating the Unique Challenge of Pulmonary Hypertension From Left-to-Right PDA Shunts in Two Cases of Congenital Diaphragmatic Hernia.
    Echocardiography. 2026;43:e70396.
    PubMed         Abstract available
    
    

    
    Eur Heart J Digit Health

11. ALNASSER TN, Hokmabadi A, Checkley EW, Sharkey MJ, et al
    A fully automated explainable predictive model for diagnosing pre-capillary and post-capillary pulmonary hypertension on routine unenhanced CT: results from the ASPIRE registry.
    Eur Heart J Digit Health. 2025;7:ztaf124.
    PubMed         Abstract available
    
    

    
    Eur J Clin Invest

12. TOCCI G, Santi M, Viola C, Pancani R, et al
    Stress testing in the diagnosis and early screening of chronic thromboembolic pulmonary disease with and without pulmonary hypertension.
    Eur J Clin Invest. 2026;56:e70175.
    PubMed         Abstract available
    
    

    
    Eur Respir J

13. LIU C, Qiu BC, Li SP, Ma JS, et al
    sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2026 Jan 22:2502367. doi: 10.1183/13993003.02367-2025.
    PubMed         Abstract available
    
    
14. YOGESWARAN A, Kremer NC, Tello K
    Multi-beat right ventricular-pulmonary arterial coupling and survival in pulmonary hypertension: are we missing the right signals?
    Eur Respir J. 2026;67:2502501.
    PubMed        
    
    

    
    Hepatol Res

15. SATOH A, Soyama A, Matsushima H, Kinoshita A, et al
    Liver Transplantation for a Patient With Hemophilia and HIV/HCV Coinfection Complicated by Pulmonary Hypertension.
    Hepatol Res. 2026 Jan 19. doi: 10.1111/hepr.70121.
    PubMed         Abstract available
    
    

    
    Hypertension

16. JANKAUSKAS SS, Kansakar U, Varzideh F, Santulli G, et al
    IL-33 Drives Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension.
    Hypertension. 2026;83:e26356.
    PubMed        
    
    
17. BECHER C, Groeneveld EJ, Quarck R, Neep B, et al
    BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial Hypertension.
    Hypertension. 2026;83:e24916.
    PubMed         Abstract available
    
    
18. LIU J, Hou L, Yang J, Xu Z, et al
    Development and Characterization of a Novel Chronic Thromboembolic Pulmonary Hypertension Rat Model: Identifying Sell-Podxl as Potential Regulators.
    Hypertension. 2026 Jan 22. doi: 10.1161/HYPERTENSIONAHA.125.25589.
    PubMed         Abstract available
    
    
19. LI P, Zhang B, Wang J, Li W, et al
    XLOC_010588 Promotes Mitophagy Via BAG2-Mediated PINK1 Stabilization in HPH.
    Hypertension. 2026;83:e25742.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

20. MORGAN C, Southgate L, Calder A, Sekar T, et al
    SOX17 variants are associated with severe pulmonary arterial hypertension with and without congenital heart disease.
    Int J Cardiol. 2026;447:134114.
    PubMed         Abstract available
    
    

    
    Intern Emerg Med

21. CATALANI F, Valeriani E, Ageno W, Campello E, et al
    Anticoagulation in chronic thromboembolic pulmonary hypertension: an updated systematic review and meta-analysis.
    Intern Emerg Med. 2026 Jan 20. doi: 10.1007/s11739-025-04257.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

22. TELLO K, Delcroix M, Pausch C, Huscher D, et al
    Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.
    J Heart Lung Transplant. 2026;45:284-288.
    PubMed         Abstract available
    
    
23. KREMER N, Glocker F, Schaefer S, Janetzko P, et al
    Method for generating right ventricular pressure-volume loops in routine practice.
    J Heart Lung Transplant. 2026;45:273-281.
    PubMed         Abstract available
    
    

    
    J Hepatol

24. TELLEZ L, Donate J, Guerrero A, Beraza IA, et al
    Early portopulmonary hypertension predicts mortality in patients with cirrhosis: insights from the PORTO-DETECT cohort.
    J Hepatol. 2025 Oct 9:S0168-8278(25)02490-0. doi: 10.1016/j.jhep.2025.
    PubMed         Abstract available
    
    

    
    J Natl Med Assoc

25. SEEDAHMED MI, Okereke J, Al-Qadi MO
    Pulmonary hypertension in a distinct IgG4-high phenotype of sarcoidosis: A case series.
    J Natl Med Assoc. 2026 Jan 22:S0027-9684(25)00363.
    PubMed         Abstract available
    
    

    
    JACC Case Rep

26. CHEONG AP, Lam LT, Ng LH, Luk NHV, et al
    Pulmonary Artery Denervation With Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation and Pulmonary Hypertension.
    JACC Case Rep. 2026 Jan 2:106577. doi: 10.1016/j.jaccas.2025.106577.
    PubMed         Abstract available
    
    

    
    Mayo Clin Proc

27. CUETO-ROBLEDO G, Graniel-Palafox LE, Roldan-Valadez E
    Pulmonary Hypertension Unmasking Unilateral Absence of the Pulmonary Artery in Congenital Scoliosis.
    Mayo Clin Proc. 2026 Jan 23:S0025-6196(25)00507.
    PubMed        
    
    

    
    Medicine (Baltimore)

28. CHEN R, Ye W, Yang Y, Liao H, et al
    Role of hsa-miR-122-5p in chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease: Targeting PIK3CG in the PI3K/Akt signaling pathway.
    Medicine (Baltimore). 2026;105:e47210.
    PubMed         Abstract available
    
    

    
    medRxiv

29. YU Z, Chen Y, Zhang M, Feng N, et al
    Risk of Group 2 Pulmonary Hypertension in Newly Diagnosed Heart Failure: An EHR-Based Cohort Analysis.
    medRxiv [Preprint]. 2025 Dec 9:2025.12.03.25341274.
    PubMed         Abstract available
    
    

    
    Nat Med

30. HERNANDEZ M, Winicki NM, Puerta CD, Lakshminarayanan S, et al
    The NOTCH3 extracellular domain is a serum biomarker for pulmonary arterial hypertension.
    Nat Med. 2026;32:306-317.
    PubMed         Abstract available
    
    

    
    Ocul Immunol Inflamm

31. FREYALDENHOVEN KJ, Johnson JA, Terrazas A, Alsaloum P, et al
    Cardiopulmonary Outcomes in Sarcoidosis Patients with Ocular Involvement: A Propensity-Score-Matched Analysis.
    Ocul Immunol Inflamm. 2026;34:64-72.
    PubMed         Abstract available
    
    

    
    Pulm Circ

32. UPHUS JAG, Hu JR, Huang S, Hofbauer TM, et al
    Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70246.
    PubMed         Abstract available
    
    
33. LIU G, Tian H, Tan J, Liu Y, et al
    Resistin-Like Molecule Beta Participates in Calcium Regulation Via Direct Interaction With CaSR and a PLC-IP(3)R-Dependent Mechanism in Hypoxia-Induced Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70247.
    PubMed         Abstract available
    
    

    
    Respir Res

34. CUI XH, Yu LL, Yang M, Liu W, et al
    Serum metabolomic profiles linking diabetes mellitus to pulmonary hypertension: a prospective cohort study with mediation analysis and risk prediction.
    Respir Res. 2026 Jan 19. doi: 10.1186/s12931-026-03499.
    PubMed        
    
    

    
    Signal Transduct Target Ther

35. CAI C, Ni G, Chen L, Deng C, et al
    Altitude hypoxia and hypoxemia: pathogenesis and management.
    Signal Transduct Target Ther. 2026;11:27.
    PubMed         Abstract available
    
    

    
    Stem Cell Res

36. FERNANDEZ VALLONE V, Fischer K, Kuchler J, Diekmann F, et al
    Generation of 5 hiPSC lines from pediatric patients with Heritable pulmonary arterial hypertension (HPAH) caused by heterozygous mutations in the TBX4 gene.
    Stem Cell Res. 2026;90:103886.
    PubMed         Abstract available
    
    

    
    Ther Adv Musculoskelet Dis

37. IANNONE C, Stano S, Pellico MR, Cito A, et al
    Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension.
    Ther Adv Musculoskelet Dis. 2026;18:1759720X251410681.
    PubMed         Abstract available
    
    

    
    Ther Umsch

38. HERTIG D, Lichtblau M, Furian M, Ulrich S, et al
    [Acute high-altitude illnesses - Definition, Prophylaxis, Therapy].
    Ther Umsch. 2025;82:209-214.
    PubMed         Abstract available
    
    

    
    Vascul Pharmacol

39. BIONDI F, Ghelardoni S, Morrone D, De Caterina R, et al
    Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis.
    Vascul Pharmacol. 2026 Jan 20:107580. doi: 10.1016/j.vph.2025.107580.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.